article thumbnail

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

OTC drugs come in various forms, including tablets, capsules, creams, and liquids, and are generally labeled with clear instructions on proper usage and dosage. Its OTC drug section covers a broad range of OTC medications, offering detailed descriptions, recommended dosages, and potential drug interactions.

article thumbnail

How authentication of drugs has become a fundamental pillar of patient safety

Express Pharma

Counterfeit drugs, intentionally mislabeled or misrepresented, often contain substandard or harmful ingredients, incorrect dosages, or no active ingredients at all. This widespread issue has led to treatment failures, adverse reactions, and even loss of life among patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US FDA approves AbbVie-Janssen’s Imbruvica for cGVHD in children

Pharmaceutical Technology

The dosage indicated for patients aged one year to under 12 years is once a day, oral 240mg/m2 dose of Imbruvica. Imbruvica's safety was reported to be in line with its established profile and the observed adverse reactions (ARs) were similar to those seen in adults with moderate to severe cGVHD.

article thumbnail

Hypertension

RX Note

Resistant Hypertension Resistant hypertension is defined by a patient whose BP is not controlled on three or more drugs (including a diuretic). After excluding medication non-adherence and isolated office hypertension, a quick check on the possible causes of resistant is required.

article thumbnail

BeiGene’s Brukinsa FDA approved for CLL/SLL

pharmaphorum

The most common adverse reactions noted in the clinical trials of zanubrutinib were neutrophil count decrease (42%), upper respiratory tract infection (39%), platelet count decrease (34%), haemorrhage (30%), and musculoskeletal pain (30%). The median DOR was not reached in either arm, however, after a median follow-up of 14.1

article thumbnail

FDA Releases Draft Labeling Guidance for Biosimilar Products

Big Molecule Watch

When information specific to the reference product is described in the biosimilar or interchangeable biosimilar product’s labeling (for example, data from clinical trials of the reference product in the ADVERSE REACTIONS and CLINICAL STUDIES sections), the reference product’s proper name should be used.

article thumbnail

The 7 Most Common Nutrient Deficiencies in Hashimoto’s

The Thyroid Pharmacist

However, in this article, I offer a brief overview of each, along with recommended products and dosages. Please note: All dosage recommendations in this article are intended for adults. Special Considerations: If you have an adverse reaction to thiamine (which is rare), I recommend detoxifying the liver with a liver support protocol.